IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $805,000 | +32.8% | 9,474 | -44.6% | 0.00% | 0.0% |
| Q2 2020 | $606,000 | +224.1% | 17,106 | +23.1% | 0.00% | +200.0% |
| Q1 2020 | $187,000 | -53.1% | 13,900 | -26.5% | 0.00% | -50.0% |
| Q4 2019 | $399,000 | -1.2% | 18,900 | -38.2% | 0.00% | +100.0% |
| Q3 2019 | $404,000 | -59.2% | 30,600 | -57.2% | 0.00% | -75.0% |
| Q2 2019 | $991,000 | -29.7% | 71,451 | -2.6% | 0.00% | -33.3% |
| Q1 2019 | $1,409,000 | +28.9% | 73,351 | -4.3% | 0.01% | 0.0% |
| Q4 2018 | $1,093,000 | -29.5% | 76,651 | +3.0% | 0.01% | -14.3% |
| Q3 2018 | $1,550,000 | +1.5% | 74,451 | +15.3% | 0.01% | 0.0% |
| Q2 2018 | $1,527,000 | +1227.8% | 64,551 | +136.5% | 0.01% | +600.0% |
| Q1 2014 | $115,000 | -8.7% | 27,300 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $126,000 | -33.3% | 27,300 | -10.5% | 0.00% | 0.0% |
| Q3 2013 | $189,000 | – | 30,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 17,714,461 | $368,992,000 | 16.94% |
| ACUTA CAPITAL PARTNERS, LLC | 2,055,500 | $42,816,000 | 15.27% |
| Foresite Capital Management III, LLC | 2,691,729 | $56,069,000 | 12.37% |
| Foresite Capital Management IV, LLC | 1,231,543 | $25,653,000 | 8.41% |
| NEXTHERA CAPITAL LP | 1,398,577 | $29,132,000 | 5.58% |
| Palo Alto Investors LP | 5,013,764 | $104,437,000 | 4.22% |
| Ghost Tree Capital, LLC | 883,823 | $18,410,000 | 3.91% |
| First Light Asset Management, LLC | 1,151,622 | $23,988,000 | 3.87% |
| DLD Asset Management, LP | 3,403,000 | $70,918,000 | 3.51% |
| RA Capital Management | 3,119,778 | $64,985,000 | 3.47% |